Clinical trial

A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With…

NCT00400608 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00400608
Title A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
Official title A Repeat-dose, Open-label, Randomized, Incomplete Block Design in Pediatric Subjects With Asthma, Ages 4 - 11 Years, to Compare Systemic Exposure and Pharmacodynamics of Fluticasone Propionate and Salmeterol Following Advair HFA 45/21mcg (2 Inhalations), ADVAIR® HFA 45/21mcg (2 Inhalations) With…
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions ADVAIR HFA, ADVAIR DISKUS
Enrollment 28
Start date Oct 1, 2006
Completion Feb 1, 2007
First posted Nov 17, 2006
Last update posted Oct 28, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies